Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Poly(ADP-ribose) polymerase (PARP-)inhibitors as genetically based precision therapy in metastatic castration-resistent prostate cancer (mCRPC)].
Heidegger I, Becker C, Tsaur I, Todenhöfer T; Fachgruppe Molekulare Urologie der Arbeitsgruppe urologische Forschung (AuF) der Deutschen Gesellschaft für Urologie. Heidegger I, et al. Among authors: todenhofer t. Urologe A. 2022 Feb;61(2):187-192. doi: 10.1007/s00120-021-01754-8. Epub 2022 Jan 10. Urologe A. 2022. PMID: 35013792 German.
[Systemic treatment of advanced prostate cancer].
Kretschmer A, Todenhöfer T. Kretschmer A, et al. Among authors: todenhofer t. Urologe A. 2020 Dec;59(12):1565-1576. doi: 10.1007/s00120-020-01381-9. Urologe A. 2020. PMID: 33201295 Review. German.
[Molecular diagnostics of bladder cancer-practical ramifications].
Schulz GB, Stief CG, Saar M, Vögeli TA, Todenhöfer T, Knüchel R, Gaisa NT. Schulz GB, et al. Among authors: todenhofer t. Urologe A. 2021 Oct;60(10):1349-1358. doi: 10.1007/s00120-021-01640-3. Epub 2021 Sep 22. Urologe A. 2021. PMID: 34550396 German.
Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer.
Kwan EM, Fettke H, Docanto MM, To SQ, Bukczynska P, Mant A, Pook D, Ng N, Graham LK, Mangiola S, Segelov E, Mahon K, Davis ID, Parente P, Pezaro C, Todenhöfer T, Horvath LG, Azad AA. Kwan EM, et al. Among authors: todenhofer t. Eur Urol Focus. 2021 Jan;7(1):63-70. doi: 10.1016/j.euf.2019.04.020. Epub 2019 May 15. Eur Urol Focus. 2021. PMID: 31103601
[Advanced prostate cancer - modern therapies, better prognosis?].
Westhofen T, Chaloupka M, Herlemann A, Todenhöfer T, Stief CG, Kretschmer A. Westhofen T, et al. Among authors: todenhofer t. MMW Fortschr Med. 2021 Apr;163(7):41-43. doi: 10.1007/s15006-021-9748-3. MMW Fortschr Med. 2021. PMID: 33844223 Review. German. No abstract available.
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer.
To SQ, Kwan EM, Fettke HC, Mant A, Docanto MM, Martelotto L, Bukczynska P, Ng N, Graham LK, Parente P, Pezaro C, Mahon K, Horvath L, Todenhöfer T, Azad AA. To SQ, et al. Among authors: todenhofer t. Eur Urol. 2018 Jun;73(6):818-821. doi: 10.1016/j.eururo.2018.01.007. Eur Urol. 2018. PMID: 29398263
191 results